David Collins

959 total citations
27 papers, 565 citations indexed

About

David Collins is a scholar working on Geriatrics and Gerontology, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David Collins has authored 27 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 7 papers in General Health Professions and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David Collins's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (4 papers) and Patient Safety and Medication Errors (3 papers). David Collins is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (4 papers) and Patient Safety and Medication Errors (3 papers). David Collins collaborates with scholars based in Australia, United States and United Kingdom. David Collins's co-authors include Danielle A Stowasser, R.D. Myers, Michael Stowasser, Barry E. Gidal, Shalom I. Benrimoj, Kay Stewart, Ernesto Jaramillo, Agnes Gebhard, Geoffrey Berry and Susan van den Hof and has published in prestigious journals such as PLoS ONE, Neurobiology of Aging and The Canadian Journal of Psychiatry.

In The Last Decade

David Collins

26 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Collins Australia 14 243 152 106 89 77 27 565
Thor Hilberg Norway 14 225 0.9× 124 0.8× 62 0.6× 65 0.7× 53 0.7× 26 842
L. Sørensen Australia 11 333 1.4× 97 0.6× 75 0.7× 28 0.3× 72 0.9× 26 801
Michael E. Pitterle United States 22 324 1.3× 428 2.8× 225 2.1× 58 0.7× 145 1.9× 46 1.1k
Timothy E. Welty United States 17 224 0.9× 421 2.8× 48 0.5× 112 1.3× 147 1.9× 53 1.1k
Ahmet Akıcı Türkiye 16 264 1.1× 165 1.1× 40 0.4× 29 0.3× 104 1.4× 86 794
Jordan R. Covvey United States 18 149 0.6× 155 1.0× 25 0.2× 47 0.5× 176 2.3× 74 1.2k
Nailya Bulatova Jordan 18 286 1.2× 145 1.0× 62 0.6× 13 0.1× 41 0.5× 61 816
Veronica Sendersky United States 6 148 0.6× 64 0.4× 31 0.3× 20 0.2× 53 0.7× 9 522
Mohammadreza Javadi Iran 17 310 1.3× 91 0.6× 142 1.3× 15 0.2× 109 1.4× 43 699
Ronald S. Hadsall United States 13 257 1.1× 143 0.9× 45 0.4× 22 0.2× 158 2.1× 36 697

Countries citing papers authored by David Collins

Since Specialization
Citations

This map shows the geographic impact of David Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Collins more than expected).

Fields of papers citing papers by David Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Collins. The network helps show where David Collins may publish in the future.

Co-authorship network of co-authors of David Collins

This figure shows the co-authorship network connecting the top 25 collaborators of David Collins. A scholar is included among the top collaborators of David Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Collins. David Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Mathis, Amanda, David Collins, Sylvia Dobo, et al.. (2022). Pharmacokinetics and Safety of the Nucleoside Analog Antiviral Drug Galidesivir Administered to Healthy Adult Subjects. Clinical Pharmacology in Drug Development. 11(4). 467–474. 10 indexed citations
4.
5.
Collins, David, et al.. (2014). The costs of integrated community case management (iCCM) programs: A multi–country analysis. Journal of Global Health. 4(2). 20407–20407. 29 indexed citations
6.
Benrimoj, Shalom I., et al.. (2003). Clinical significance of clinical interventions in community pharmacy: a randomised trial of the effect of education and a professional allowance. International Journal of Pharmacy Practice. 11(2). 81–87. 7 indexed citations
7.
Benrimoj, Shalom I., et al.. (2003). Clinical intervention rates in community pharmacy: a randomised trial of the effect of education and a professional allowance. International Journal of Pharmacy Practice. 11(2). 71–80. 24 indexed citations
8.
Stowasser, Danielle A, David Collins, & Michael Stowasser. (2002). A Randomised Controlled Trial of Medication Liaison Services—Acceptance and Use by Health Professionals. Journal of Pharmacy Practice and Research. 32(3). 221–226. 12 indexed citations
9.
Stowasser, Danielle A, David Collins, & Michael Stowasser. (2002). A Randomised Controlled Trial of Medication Liaison Services—Patient Outcomes. Journal of Pharmacy Practice and Research. 32(2). 133–140. 88 indexed citations
10.
Benrimoj, Shalom I., et al.. (2000). Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy. PharmacoEconomics. 18(5). 459–468. 50 indexed citations
11.
Stowasser, Danielle A, Christine E. Staatz, Michael Stowasser, Judith Coombes, & David Collins. (2000). Identifying Drug‐Related ReadmissionsIs There a Better Way of Assessing the Contribution of Adverse Medication Events?. The Australian Journal of Hospital Pharmacy. 30(2). 47–53. 8 indexed citations
12.
Gidal, Barry E., et al.. (1997). Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy. Epilepsy Research. 28(3). 207–211. 21 indexed citations
13.
Stowasser, Danielle A, et al.. (1997). Information Quality A Major Consideration in the Development of Medication Liaison Services. The Australian Journal of Hospital Pharmacy. 27(5). 362–366. 23 indexed citations
14.
Holle, Lisa M., Barry E. Gidal, & David Collins. (1995). Valproate in Status Epilepticus. Annals of Pharmacotherapy. 29(10). 1042–1044. 17 indexed citations
15.
Gidal, Barry E., et al.. (1993). Apparent Valproic Acid Neurotoxicity in a Hypoalbuminemic Patient. Annals of Pharmacotherapy. 27(1). 32–35. 26 indexed citations
16.
Dovey, Susan, et al.. (1992). General practitioners' views on the role of the community pharmacist.. PubMed. 105(943). 403–5. 16 indexed citations
17.
Rezvani, Amir H., David Collins, & Arlene C. Seña. (1989). Measurement of Extracellular Calcium Ions within the Hypothalamus of the Freely-Moving Cat: A Novel Approach. Journal of Liquid Chromatography & Related Technologies. 12(8). 1323–1332. 1 indexed citations
18.
Collins, David, J. Paul Fawcett, & C. G. Rammell. (1981). Determination of sodium fluoroacetate (compound 1080) in poison baits by HPLC. Bulletin of Environmental Contamination and Toxicology. 26(1). 669–673. 20 indexed citations
19.
Collins, David & Deborah A. Bowen. (1953). Isoniazid in the treatment of pulmonary tuberculosis. Tubercle. 34(1). 8–13. 6 indexed citations
20.
Collins, David. (1952). Symptomatic Purpura during Isoniazid Therapy. BMJ. 2(4780). 391.4–392. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thor Hilberg Breakdown of academic impact, for papers by L. Sørensen Breakdown of academic impact, for papers by Michael E. Pitterle Breakdown of academic impact, for papers by Timothy E. Welty Breakdown of academic impact, for papers by Ahmet Akıcı Breakdown of academic impact, for papers by Jordan R. Covvey Breakdown of academic impact, for papers by Nailya Bulatova Breakdown of academic impact, for papers by Veronica Sendersky Breakdown of academic impact, for papers by Mohammadreza Javadi Breakdown of academic impact, for papers by Ronald S. Hadsall
Rankless by CCL
2026